The Live Green Co

Scaffold Therapeutics, based in Boston, MA, is pioneering a unique drug discovery platform focused on RNA biology, targeting clinically validated and first-in-class biology in oncology, neurodegeneration, and other therapeutic areas. The company's research emphasizes the regulation of RNA modifications that influence its stability, transcription, and degradation. Recently, Scaffold Therapeutics has partnered with QureALZ, a company dedicated to advancing research on Alzheimer's and other neurodegenerative disorders. This collaboration aims to leverage Scaffold's drug discovery platform and expertise to explore treatments for a variety of diseases, including Alzheimer's, ALS, and brain cancer. Generated from the website

AOA Dx is a biotechnology company with a team of entrepreneurs that brings innovative, impactful, and cost-effective medical technologies from research and development into the hands of providers and patients. The company is driven by a mission is to bring to market the first accurate early-stage non-invasive ovarian cancer diagnostic test that will improve clinical practice, help reduce patient mortality and deliver cost savings to payers.

Niviron was founded in 2021. The company is based in Boston, Massachusetts, USA. The main goal of the company is to extend the humanlife span by advancement new technologies aimed at the treatment of oncological diseases. The company focuses on research in the field of cancer therapy with oncolytic viruses. Our attention is focused on the main approaches of viral cancer therapy: 1. Activation and targeting of the tumor by the immune system; 2. Destruction of cancer cells directly by an oncolytic virus; 3. Impact on the tumor microenvironment.